Asset Lead Retinal Health Japan

Tasks & Responsibilities

• As Asset Lead Japan you play a key cross-functional role in bringing important assets within Retinal Health to the Japanese market. Within Boehringer Ingelheim this role is viewed as business critical and of high strategic importance.

• You drive asset development and are accountable for maximizing asset value and accelerating asset launch. You are the main driver of strategic decisions and the integrator of complex cross-functional deliverables. You will lead a cross-functional team and integrate a multitude of deliverables along the product development and delivery path.

• You report to Head of Therapeutic Area (TA). You will lead a strong cross functional Asset Team consisting of a Value Lead, Evidence Lead and Program Manager. The Asset team works closely with the value and evidence networks within Nippon Boehringer Ingelheim to create and execute on a comprehensive end to end Asset Development Strategy in alignment with Global Asset priorities and the overall TA portfolio, disease areas.

• Drives key commercial, strategic decisions, endorses, and integrates cross functional strategies and executional plans into a consolidated Asset strategy (including Financial, Evidence generation, Regulatory, Brand, Patient Access, and Manufacturing plans).

• Accountable for asset Target Product Profile and Value proposition; in cooperation with a broader group of internal and external stakeholders creates commercial value of the asset, integrates scientific strategy (working with Evidence Lead) ensuring it can address clinical unmet need and improve current standard of care.

• You are the single point of accountability for Local and Global stakeholders, driving seamless execution of asset deliverables and decision making for the asset ensuring the strategy is managed in a cost-effective manner with appropriate resources.

• Accountable for integrating asset budget and development timelines, implementation of risk mitigation plan and identification of new opportunities for the asset.

• You act as point of contact and lead voice of the Asset Team externally and internally. You are responsible to cross-functionally govern the asset and manages other decision-making bodies to drive the asset strategy forward. You are responsible for the development and approval of program plans by Therapeutic Area Leadership Committee and to escalate to Human Pharma Leadership Committee and Global Asset Teams when necessary.

• You serve as a coach to Asset team members, provides input into their performance review and strive to build a highly motivated, cohesive, and empowered asset team and stimulate cross-functional collaboration within the value and evidence networks. You will promote a culture of innovation and an ability to accelerate brining transformative therapies to patients.

• Collaborates with other Asset Leads to ensure consistency of processes across Asset Teams.

Requirements

• Advanced degree in Medical or Life Science, MD, PhD or MBA or equivalent experience.

• Accomplished industry professional with a broad knowledge of all phases of drug development and commercialization; usually clinical or commercial background with strong strategic skills and strong business acumen.

• Several years of experience in end-to-end leadership of a cross-functional team to deliver successful clinical development program or commercialization or a complex development project with substantial budget.

• Experience in developing business plans, successfully managing budgets and timelines, and implementing key decisions to prioritize timelines, budget and resources to support a long-term success of a project.

• A visionary leader with an entrepreneurial mind-set and passion to build a strong team and team culture of high performance, create opportunities, solve problems, and successfully drive complex projects.

• Able to engage with Sr. Executives across the organization to prioritize funding, align and validate decisions and support programs.

• Confident in making independent decisions and prioritizing in ambiguous environment.

• Broad exposure to all the activities involved in successfully developing and launching assets and brands in respective diseases/indications/TAs (HP Supply, Commercial, Market Access, Regulatory, Patient Safety & Pharmacovigilance, Program Management, Medical Affairs, etc., and substantial cross-functional interaction); experience in design and execution of clinical programs (preferred).

• Long term relevant experience in drug development industry with track record of increasing responsibility (preferred).

• Global market-relevant experience, including external stakeholder engagement in the therapeutic area of Retinal Health. Track record of successful launches (preferred).

All qualified applicants will receive consideration for employment without regard to a person’s actual or perceived race, including natural hairstyles, hair texture and protective hairstyles; color; creed; religion; national origin; age; ancestry; citizenship status, marital status; gender, gender identity or expression; sexual orientation, mental, physical or intellectual disability, veteran status; pregnancy, childbirth or related medical condition; genetic information (including the refusal to submit to genetic testing) or any other class or characteristic protected by applicable law.